Literature DB >> 25619964

Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.

Mark E Lobatto1, Claudia Calcagno, Antoine Millon, Max L Senders, Francois Fay, Philip M Robson, Sarayu Ramachandran, Tina Binderup, Maarten P M Paridaans, Steven Sensarn, Stephan Rogalla, Ronald E Gordon, Luis Cardoso, Gert Storm, Josbert M Metselaar, Christopher H Contag, Erik S G Stroes, Zahi A Fayad, Willem J M Mulder.   

Abstract

Atherosclerosis is a major cause of global morbidity and mortality that could benefit from novel targeted therapeutics. Recent studies have shown efficient and local drug delivery with nanoparticles, although the nanoparticle targeting mechanism for atherosclerosis has not yet been fully elucidated. Here we used in vivo and ex vivo multimodal imaging to examine permeability of the vessel wall and atherosclerotic plaque accumulation of fluorescently labeled liposomal nanoparticles in a rabbit model. We found a strong correlation between permeability as established by in vivo dynamic contrast enhanced magnetic resonance imaging and nanoparticle plaque accumulation with subsequent nanoparticle distribution throughout the vessel wall. These key observations will enable the development of nanotherapeutic strategies for atherosclerosis.

Entities:  

Keywords:  DCE-MRI; atherosclerosis; imaging; in vivo microscopy; nanomedicine; nanoparticle; targeting

Mesh:

Substances:

Year:  2015        PMID: 25619964      PMCID: PMC4492477          DOI: 10.1021/nn506750r

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  39 in total

1.  Miniature near-infrared dual-axes confocal microscope utilizing a two-dimensional microelectromechanical systems scanner.

Authors:  Jonathan T C Liu; Michael J Mandella; Hyejun Ra; Larry K Wong; Olav Solgaard; Gordon S Kino; Wibool Piyawattanametha; Christopher H Contag; Thomas D Wang
Journal:  Opt Lett       Date:  2007-02-01       Impact factor: 3.776

2.  Efficient rejection of scattered light enables deep optical sectioning in turbid media with low-numerical-aperture optics in a dual-axis confocal architecture.

Authors:  Jonathan T C Liu; Michael J Mandella; James M Crawford; Christopher H Contag; Thomas D Wang; Gordon S Kino
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

3.  Three-dimensional in vivo imaging by a handheld dual-axes confocal microscope.

Authors:  Hyejun Ra; Wibool Piyawattanametha; Michael J Mandella; Pei-Lin Hsiung; Jonathan Hardy; Thomas D Wang; Christopher H Contag; Gordon S Kino; Olav Solgaard
Journal:  Opt Express       Date:  2008-05-12       Impact factor: 3.894

Review 4.  Understanding biophysicochemical interactions at the nano-bio interface.

Authors:  Andre E Nel; Lutz Mädler; Darrell Velegol; Tian Xia; Eric M V Hoek; Ponisseril Somasundaran; Fred Klaessig; Vince Castranova; Mike Thompson
Journal:  Nat Mater       Date:  2009-06-14       Impact factor: 43.841

5.  Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging.

Authors:  Peter A Jarzyna; Torjus Skajaa; Anita Gianella; David P Cormode; Daniel D Samber; Stephen D Dickson; Wei Chen; Arjan W Griffioen; Zahi A Fayad; Willem J M Mulder
Journal:  Biomaterials       Date:  2009-09-23       Impact factor: 12.479

6.  In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging.

Authors:  Ulrich Flögel; Zhaoping Ding; Hendrik Hardung; Sebastian Jander; Gaby Reichmann; Christoph Jacoby; Rolf Schubert; Jürgen Schrader
Journal:  Circulation       Date:  2008-06-23       Impact factor: 29.690

Review 7.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.

Authors:  David P Cormode; Torjus Skajaa; Matti M van Schooneveld; Rolf Koole; Peter Jarzyna; Mark E Lobatto; Claudia Calcagno; Alessandra Barazza; Ronald E Gordon; Pat Zanzonico; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Nano Lett       Date:  2008-10-22       Impact factor: 11.189

9.  Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.

Authors:  Claudia Calcagno; Jean-Christophe Cornily; Fabien Hyafil; James H F Rudd; Karen C Briley-Saebo; Venkatesh Mani; Gregg Goldschlager; Josef Machac; Valentin Fuster; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-08       Impact factor: 8.311

10.  MR imaging of adventitial vasa vasorum in carotid atherosclerosis.

Authors:  W S Kerwin; M Oikawa; C Yuan; G P Jarvik; T S Hatsukami
Journal:  Magn Reson Med       Date:  2008-03       Impact factor: 4.668

View more
  36 in total

1.  Europium-phenolic network coated BaGdF5 nanocomposites for tri-modal computed tomography/magnetic resonance/luminescence imaging.

Authors:  Wei Zhu; Shuang Liang; Jing Wang; Zhe Yang; Li Zhang; Tianmeng Yuan; Zushun Xu; Haibo Xu; Penghui Li
Journal:  J Mater Sci Mater Med       Date:  2017-03-30       Impact factor: 3.896

Review 2.  Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease.

Authors:  Mallika Modak; Molly A Frey; Sijia Yi; Yugang Liu; Evan A Scott
Journal:  Curr Opin Biotechnol       Date:  2020-07-15       Impact factor: 9.740

3.  Intraplaque and Cellular Distribution of Dextran-Coated Iron Oxide Fluorescently Labeled Nanoparticles: Insights Into Atherothrombosis and Plaque Rupture.

Authors:  Claudia Calcagno; Zahi A Fayad
Journal:  Circ Cardiovasc Imaging       Date:  2017-05       Impact factor: 7.792

4.  Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.

Authors:  Mark E Lobatto; Tina Binderup; Philip M Robson; Luuk F P Giesen; Claudia Calcagno; Julia Witjes; Francois Fay; Samantha Baxter; Chang Ho Wessel; Mootaz Eldib; Jason Bini; Sean D Carlin; Erik S G Stroes; Gert Storm; Andreas Kjaer; Jason S Lewis; Thomas Reiner; Zahi A Fayad; Willem J M Mulder; Carlos Pérez-Medina
Journal:  Bioconjug Chem       Date:  2019-06-07       Impact factor: 4.774

5.  Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.

Authors:  Bhabatosh Banik; Ru Wen; Sean Marrache; Anil Kumar; Nagesh Kolishetti; Elizabeth W Howerth; Shanta Dhar
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

6.  Collagenase-Cleavable Peptide Amphiphile Micelles as a Novel Theranostic Strategy in Atherosclerosis.

Authors:  Deborah D Chin; Christopher Poon; Noah Trac; Jonathan Wang; Jackson Cook; Johan Joo; Zhangjingyi Jiang; Naomi Sulit Sta Maria; Russell E Jacobs; Eun Ji Chung
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

Review 7.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19

8.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

9.  Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques.

Authors:  Claudia Calcagno; Mark E Lobatto; Hadrien Dyvorne; Philip M Robson; Antoine Millon; Max L Senders; Olivier Lairez; Sarayu Ramachandran; Bram F Coolen; Alexandra Black; Willem J M Mulder; Zahi A Fayad
Journal:  NMR Biomed       Date:  2015-08-30       Impact factor: 4.044

10.  Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis.

Authors:  Sijia Yi; Sean David Allen; Yu-Gang Liu; Brian Zhou Ouyang; Xiaomo Li; Punn Augsornworawat; Edward Benjamin Thorp; Evan Alexander Scott
Journal:  ACS Nano       Date:  2016-12-09       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.